EndeavorRx is an FDA-approved game that requires a prescription to play

Modesto Morganelli
Giugno 16, 2020

It is created to be used as part of a wider therapy regimen, which may also include medication or educational programs, to help improve attention in children 8 to 12 years old.

"The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics", said Jeffrey Shuren from the US Food and Drug Administration (FDA) which gave permission for it be used as a treatment.

The game is called EndeavorRx and was developed by Akili Interactive.

It's "designed for the targeted activation of specific neural systems in the brain", says developer Akili, using sensory and motor challenges.

"We're proud to make history today with FDA's decision", Akili CEO Eddie Martucci said in a statement. It doesn't look like much, admittedly, but the game underwent seven years of clinical trials that studied over 600 children to determine whether the game could actually help with ADHD.

"EndeavorRx is indicated to improve attention function as measured by computer-based testing and is the first digital therapeutic meant to improve symptoms associated with ADHD", reads the press release from the FDA, "as well as the first game-based therapeutic granted marketing authorization by the FDA for any type of condition". Common side effects included frustration (get good, kid) and headaches, which is obviously minor compared to what most prescription drugs can cause.

However, according to one the company's five studies, one-third of kids treated "no longer had a measurable attention deficit on at least one measure of objective attention".

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE